- Home
- VIRxSYS Corporation Strategic SWOT Analysis Review
VIRxSYS Corporation Strategic SWOT Analysis Review
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Cytokine PharmaSciences, Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- by Global Data
- May 2013
- 19 pages
Summary Cytokine PharmaSciences, Inc. (CPSI) is a biopharmaceutical company. The company develops drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer .It manufactures and sells obstetric products. CPSI's ...
Industries: Biological Therapy | Countries: United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- by Global Data
- May 2013
- 36 pages
Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based solutions for the treatment of cardiovascular diseases. It has developed a regenerative medicine platform, Tissue Engineering by Self-Assembly, or TESA. CTE's product portfolio includes ...
Industries: Biological Therapy | Countries: United States
Oxford BioMedica plc (Symbol:OXB) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2013
- 40 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Oxford BioMedica plc SWOT Analysis report provides you a strategic ...
Industries: Biological Therapy | Countries: United States
iPS cell Generation patent landscape - 2013/03
- $ 6 860
- Industry report
- by France Innovation Scientifique et Transfert
- May 2013
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged tissues using differentiated cells out of stem cells. However, ethical and scientific issues are ...
Industries: Biological Therapy | Countries: United States, South Korea, China
iPS cell Differentiation patent landscape - 2013/03
- $ 4 060
- Industry report
- by France Innovation Scientifique et Transfert
- May 2013
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged tissues using differentiated cells out of stem cells. However, ethical and scientific issues are ...
Industries: Biological Therapy | Countries: United States, South Korea, China
CMC Biologics AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- April 2013
- 20 pages
Summary CMC Biologics A/S (CMC Biologics) is a contract biopharmaceutical manufacturing and development organization. It offers manufacturing services of DNA, active pharmaceutical ingredient, and others. The company's services include Cell line or strain development, cGMP cell banking, cell culture, ...
Industries: Biological Therapy | Countries: United States, Denmark
California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- April 2013
- 21 pages
Summary California Stem Cell, Inc. (CSC) is a biotechnology company, based in the US. The company manufactures human cells for therapeutic development and clinical application. It produces and supplies clinically relevant embryonic stem cell, derived human cell populations for conventional drug screening ...
Industries: Biological Therapy | Countries: United States
Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- April 2013
- 27 pages
Summary Cellartis AB (Cellartis) is a biotechnology company. The company provides pluripotent stem cells and human embryonic stem cells, and technology for drug discovery research, toxicity testing and regenerative medicine. Its products and services include iPS cell engineering service, differentiated ...
Industries: Biological Therapy | Countries: United States
California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- April 2013
- 28 pages
Summary California Institute for Regenerative Medicine (CIRM) is an orgaisation that funds stem cell research at research institutions and companies throughout California. Its grants support research with embryonic, adult and reprogrammed (iPS) stem cells, with the aim of bringing new medical therapies ...
Industries: Biological Therapy | Countries: United States
BD Biosciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- April 2013
- 21 pages
Summary BD Biosciences (BD) is a bioscience company. The company provides instruments, reagents, cell culture ware, and a wide range of services to support the work of researchers and clinicians. It offers training, support and contract services. BD's contract services include ADME/Tox research services, ...
Industries: Biological Therapy | Countries: United States
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- (866) 682 9815
ref:plp2012
Reportlinker.com © Copyright 2013. All rights reserved.
